A method of treating prostate cancer is provided. The method comprising administering to a subject in need thereof a therapeutically effective amount of an agent capable of reducing activity and/or expression of MCP-1 or of an effector thereof, thereby treating the prostate cancer in the subject.

 
Web www.patentalert.com

< Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis

< Expression of human serum albumin in plastids

> Liquid-filled chewing gum composition

> Pearl millet line 53-1-1 with PP3 gene and all derivatives produced by any method
~ 00620